Inhibitor of growth-4 is a potential target for cancer therapy

Tumor Biology ◽  
2016 ◽  
Vol 37 (4) ◽  
pp. 4275-4279 ◽  
Author(s):  
Shuping Yuan ◽  
Jianhua Jin ◽  
Juanjuan Shi ◽  
Yongzhong Hou
2004 ◽  
Vol 10 (19) ◽  
pp. 2359-2376 ◽  
Author(s):  
John Romer ◽  
Boye Nielsen ◽  
Michael Ploug

2021 ◽  
Vol 159 ◽  
pp. 103236
Author(s):  
Yan Luo ◽  
Jisheng Hu ◽  
Yong Liu ◽  
Le Li ◽  
Yilong Li ◽  
...  

2021 ◽  
Vol 911 ◽  
pp. 174516
Author(s):  
Subhajit Chatterjee ◽  
Saptarshi Sinha ◽  
Chanakya Nath Kundu

Author(s):  
Nimai Chand Chandra ◽  
Amar Preet Kaur ◽  
Ayantika Talukdar ◽  
Nimisha Saxena ◽  
Shrimanjunath Sankanagoudar

Cells ◽  
2020 ◽  
Vol 9 (6) ◽  
pp. 1483 ◽  
Author(s):  
Shujing Liang ◽  
Lifang Hu ◽  
Zixiang Wu ◽  
Zhihao Chen ◽  
Shuyu Liu ◽  
...  

Cyclin-dependent kinases (CDKs) are a group of serine/threonine protein kinases and play crucial roles in various cellular processes by regulating cell cycle and gene transcription. Cyclin-dependent kinase 12 (CDK12) is an important transcription-associated CDK. It shows versatile roles in regulating gene transcription, RNA splicing, translation, DNA damage response (DDR), cell cycle progression and cell proliferation. Recently, increasing evidence demonstrates the important role of CDK12 in various human cancers, illustrating it as both a biomarker of cancer and a potential target for cancer therapy. Here, we summarize the current knowledge of CDK12, and review the research advances of CDK12′s biological functions, especially its role in human cancers and as a potential target and biomarker for cancer therapy.


Sign in / Sign up

Export Citation Format

Share Document